|
BMS Admits to International Bribery Probe by SEC, Justice Department
Bristol-Myers Squibb (BMS) admitted the SEC has launched an investigation under the Foreign Corrupt Practices Act (FCPA) into its sales and marketing practices in various countries.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives